Literature DB >> 12074263

Construction and validation of a fatigue impact scale for daily administration (D-FIS).

John D Fisk1, Susan E Doble.   

Abstract

The fatigue impact scale (FIS) was developed previously as a symptom-specific profile measure of health-related quality of life (HRQoL) for use in medical conditions in which fatigue is a prominent chronic symptom. Thus, it was not developed to be a responsive measure of daily changes in fatigue. This study describes the development and initial validation of an adaptation of the FIS for daily use. Items for the daily fatigue impact scale (D-FIS) were selected from the pool of original FIS items through Rasch analyses of existing data. The reduced-item FIS was administered to a sample of 93 subjects with flu-like illness, 25 of whom were followed for a 21-day period. Rasch analyses were used to further reduce the scale to a minimum number of items that represented a unidimensional measure of self-reported fatigue impact. This 8-item D-FIS demonstrated good relations to flu symptom ratings and to other general health ratings. It also proved to be a responsive measure of change in reported fatigue impact for subjects who were followed longitudinally. This initial validation study indicates that the D-FIS has considerable promise as a valid measure of the subjective daily experience of fatigue.

Entities:  

Mesh:

Year:  2002        PMID: 12074263     DOI: 10.1023/a:1015295106602

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  29 in total

Review 1.  Measuring quality of life in clinical trials: a taxonomy and review.

Authors:  G H Guyatt; S J Veldhuyzen Van Zanten; D H Feeny; D L Patrick
Journal:  CMAJ       Date:  1989-06-15       Impact factor: 8.262

2.  Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use.

Authors:  M I Prince; O F James; N P Holland; D E Jones
Journal:  J Hepatol       Date:  2000-03       Impact factor: 25.083

3.  Observations are always ordinal; measurements, however, must be interval.

Authors:  B D Wright; J M Linacre
Journal:  Arch Phys Med Rehabil       Date:  1989-11       Impact factor: 3.966

4.  Impact of fatigue on the quality of life of patients with primary biliary cirrhosis.

Authors:  P M Huet; J Deslauriers; A Tran; C Faucher; J Charbonneau
Journal:  Am J Gastroenterol       Date:  2000-03       Impact factor: 10.864

5.  Fatigue in primary care: prevalence, psychiatric comorbidity, illness behavior, and outcome.

Authors:  P J Cathébras; J M Robbins; L J Kirmayer; B C Hayton
Journal:  J Gen Intern Med       Date:  1992 May-Jun       Impact factor: 5.128

6.  Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group.

Authors:  J J Treanor; F G Hayden; P S Vrooman; R Barbarash; R Bettis; D Riff; S Singh; N Kinnersley; P Ward; R G Mills
Journal:  JAMA       Date:  2000-02-23       Impact factor: 56.272

7.  Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment.

Authors:  F G Hayden; J J Treanor; R S Fritz; M Lobo; R F Betts; M Miller; N Kinnersley; R G Mills; P Ward; S E Straus
Journal:  JAMA       Date:  1999-10-06       Impact factor: 56.272

8.  A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis. The Canadian MS Research Group.

Authors: 
Journal:  Can J Neurol Sci       Date:  1987-08       Impact factor: 2.104

9.  Measuring the functional impact of fatigue: initial validation of the fatigue impact scale.

Authors:  J D Fisk; P G Ritvo; L Ross; D A Haase; T J Marrie; W F Schlech
Journal:  Clin Infect Dis       Date:  1994-01       Impact factor: 9.079

10.  Central basis of muscle fatigue in chronic fatigue syndrome.

Authors:  J A Kent-Braun; K R Sharma; M W Weiner; B Massie; R G Miller
Journal:  Neurology       Date:  1993-01       Impact factor: 9.910

View more
  34 in total

1.  Impact of fatigue in Parkinson's disease: the Fatigue Impact Scale for Daily Use (D-FIS).

Authors:  Pablo Martinez-Martin; Maria Jose Catalan; Julian Benito-Leon; Angel Ortega Moreno; Ivana Zamarbide; Esther Cubo; Nadeje van Blercon; Victor Campos Arillo; Margarita Pondal; Gurutz Linazasoro; Fernando Alonso; Pedro García Ruiz; Belen Frades
Journal:  Qual Life Res       Date:  2006-05       Impact factor: 4.147

2.  Physical activity levels at work and outside of work among commercial construction workers.

Authors:  Oscar E Arias; Alberto J Caban-Martinez; Peter E Umukoro; Cassandra A Okechukwu; Jack T Dennerlein
Journal:  J Occup Environ Med       Date:  2015-01       Impact factor: 2.162

3.  Non-alcoholic fatty liver disease is not associated with a lower health perception.

Authors:  Liat Mlynarsky; Dalit Schlesinger; Roni Lotan; Muriel Webb; Zamir Halpern; Erwin Santo; Oren Shibolet; Shira Zelber-Sagi
Journal:  World J Gastroenterol       Date:  2016-05-07       Impact factor: 5.742

4.  Chronic stress and fatigue-related quality of life after mild to moderate traumatic brain injury.

Authors:  Esther Bay; Marita B de-Leon
Journal:  J Head Trauma Rehabil       Date:  2011 Sep-Oct       Impact factor: 2.710

5.  The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Inflammatory Bowel Disease.

Authors:  Charles N Bernstein; Lixia Zhang; Lisa M Lix; Lesley A Graff; John R Walker; John D Fisk; Scott B Patten; Carol A Hitchon; James M Bolton; Jitender Sareen; Renée El-Gabalawy; James Marriott; Ruth Ann Marrie
Journal:  Inflamm Bowel Dis       Date:  2018-08-16       Impact factor: 5.325

6.  Development of a patient reported outcome scale for fatigue in multiple sclerosis: The Neurological Fatigue Index (NFI-MS).

Authors:  Roger J Mills; Carolyn A Young; Julie F Pallant; Alan Tennant
Journal:  Health Qual Life Outcomes       Date:  2010-02-12       Impact factor: 3.186

7.  Fatigue and Comorbidities in Multiple Sclerosis.

Authors:  Kirsten M Fiest; John D Fisk; Scott B Patten; Helen Tremlett; Christina Wolfson; Sharon Warren; Kyla A McKay; Lindsay I Berrigan; Ruth Ann Marrie
Journal:  Int J MS Care       Date:  2016 Mar-Apr

Review 8.  Fatigue assessment of Parkinson's disease patient in clinic: specific versus holistic.

Authors:  Cristian Falup-Pecurariu
Journal:  J Neural Transm (Vienna)       Date:  2013-01-26       Impact factor: 3.575

9.  Physical dimension of fatigue correlated with disability change over time in patients with multiple sclerosis.

Authors:  Marc Debouverie; Sophie Pittion-Vouyovitch; Hélène Brissart; Francis Guillemin
Journal:  J Neurol       Date:  2008-01-29       Impact factor: 4.849

Review 10.  Impact of newer pharmacological treatments on quality of life in patients with Parkinson's disease.

Authors:  David A Gallagher; Anette Schrag
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.